TUESDAY, July 6, 2023 (HealthDay News) — The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clinical trial results show. Nivolumab outperformed the drug brentuximab vedotin (Adcetris),Continue Reading

SUNDAY, June 4, 2023 (HealthDay News) — Skin cancer can pop up anywhere on your skin, including the soles of your feet and even under your fingernails. That’s what happened to Isabel Lievano, who was diagnosed with melanoma when her dermatologist determined that a persistent black spot under her fingernailContinue Reading